Selank
Selank overview

Selank

Injection

Strongest for sustained anti-anxiety

First effects30-60 minutes
Full benefitsWeek 1-2

Selank injection provides longer-lasting anti-anxiety and immune-modulating effects through GABA-based mechanisms. Effects may persist for days after discontinuation. Stronger for sustained anxiety management and immune support, but does not activate NMDA receptor binding sites like the nasal route.

Injection protocols

ProtocolDoseFrequency
Mild anxiety relief250mcgOnce daily
Moderate anxiety/cognitive250mcgTwice daily (morning and evening)
Intensive anxiety/stress500mcgDivided doses daily
Immune support during stress250mcgOnce daily for 2-4 weeks

Protocols are from published research literature. This is not medical advice. Dosing should be determined by a licensed clinician.

What to expect

30-60 minutes

Mild anxiety reduction begins.

Day 1-3

Improved mental clarity and focus.

Week 1

Enhanced stress resilience and emotional stability.

Week 1-2

Cognitive enhancement effects peak. Benefits may persist days after stopping.

What to know

  • Start with lowest effective dose (250mcg) to assess response
  • Strong safety profile with minimal reported side effects
  • No known tolerance, dependence, or withdrawal issues
  • Use sterile injection techniques to prevent infection
  • Consult healthcare provider if taking multiple psychiatric medications

Other ways to take Selank

How Selank works

Selank calms the nervous system by enhancing GABA activity, your brain's natural "slow down" signal, which reduces anxiety without sedation. It also balances serotonin and dopamine levels, improving mood and sharpening focus. On top of that, it boosts BDNF (a protein that supports learning and memory) in the hippocampus and helps regulate inflammatory signaling, which is why it also supports immune function.

Key research

Zozulia AA et al. · Zhurnal Nevrologii i Psikhiatrii · 2008
Medvedev VE et al. · Zhurnal Nevrologii i Psikhiatrii · 2014
Uchakina ON et al. · Zhurnal Nevrologii i Psikhiatrii · 2008
Dolotov OV et al. · Journal of Neurochemistry · 2006